Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this type of manipulation has been associated with cancer treatments, innovative companies are applying the same principles to a wide variety of diseases.
Precigen (NASDAQ:PGEN – Free Report) and NexImmune (NASDAQ:NEXI – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Insider and Institutional Ownership 61.8% of Precigen shares are held by […]
Chiron Capital Management LLC cut its position in shares of Alaunos Therapeutics, Inc. (NASDAQ:TCRT – Free Report) by 22.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 81,830 shares of the company’s stock after selling 24,060 shares during the period. Chiron […]
Alaunos Therapeutics (NASDAQ:TCRT – Get Rating) and Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation. Analyst Ratings This is a breakdown of current recommendations […]
HC Wainwright upgraded shares of Alaunos Therapeutics (NASDAQ:TCRT – Get Rating) from a neutral rating to a buy rating in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Alaunos Therapeutics’ FY2023 earnings at ($0.16) EPS, Q1 2024 earnings at ($0.04) EPS, Q2 2024 earnings at […]